U.S. FDA Overseas Staff Lacks Coordination With Agency's Centers, GAO Says
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA has no formal process for reviewing and incorporating information provided by its overseas staff into the selection of foreign drug establishments for inspection, according to the Government Accountability Office